Explore MeiraGTx Holdings's Fair Values from the Community and select yours

MeiraGTx Holdings (NASDAQ:MGTX) Second Quarter 2025 Results

Key Financial Results

• Revenue: US$3.69m (up by US$3.41m from 2Q 2024).
• Net loss: US$38.8m (loss narrowed by 20% from 2Q 2024).
• US$0.48 loss per share (improved from US$0.76 loss in 2Q 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

MeiraGTx Holdings Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 43%. Earnings per share (EPS) also missed analyst estimates by 2.7%.

Looking ahead, revenue is forecast to grow 43% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Biotechs industry in the US.

The company's shares are up 9.3% from a week ago.

Risk Analysis

You still need to take note of risks, for example - MeiraGTx Holdings has 2 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.